These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 212974
1. Comparison of the development of resistant strains of Type 1 herpes simplex virus to in vitro antiviral activity of 5-iodo-2'-deoxyuridine or ribavirin. Huffman JH, Allen LB, Sidwell RW. Ann N Y Acad Sci; 1977 Mar 04; 284(1):233-8. PubMed ID: 212974 [Abstract] [Full Text] [Related]
2. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine. Hirano A, Yumura K, Kurimura T, Katsumoto T, Moriyama H, Manabe R. Acta Virol; 1979 May 04; 23(3):226-30. PubMed ID: 41435 [Abstract] [Full Text] [Related]
3. [The synergistic antiviral effect of acyclovir and ribavirin against the herpes simplex type-1 virus and the pseudorabies virus in vitro]. Shishkov S, Pancheva S. Acta Microbiol Bulg; 1990 May 04; 25():69-75. PubMed ID: 2166426 [Abstract] [Full Text] [Related]
4. [Effect of ribamidil on the reproduction of the herpes simplex virus in a CV1 cell culture]. Linitskaia GL, Kroĭcha IuG, Galegov GA. Vopr Virusol; 1983 May 04; 28(6):673-5. PubMed ID: 6322451 [Abstract] [Full Text] [Related]
5. [In vitro sensitivity to antiviral agents of herpes simplex viruses isolated from patients with herpetic keratitis]. Mori Y, Inoue Y, Shimomura Y, Manabe R. Nippon Ganka Gakkai Zasshi; 1990 May 04; 94(5):484-7. PubMed ID: 2171305 [Abstract] [Full Text] [Related]
6. Isolation and characterization of herpes simplex virus resistant to nucleoside analogs. Katz E, Rosenblat O, Pisanty S. Oral Surg Oral Med Oral Pathol; 1991 Sep 04; 72(3):296-9. PubMed ID: 1656355 [Abstract] [Full Text] [Related]
7. Failure of type 1 herpesvirus to develop resistance to ribavirin. Allen LB, Fingal CM. Antimicrob Agents Chemother; 1977 Jul 04; 12(1):120-1. PubMed ID: 883814 [Abstract] [Full Text] [Related]
8. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2. Ayisi NK, Gupta VS, Meldrum JB, Taneja AK, Babiuk LA. Antimicrob Agents Chemother; 1980 Apr 04; 17(4):558-66. PubMed ID: 6249191 [Abstract] [Full Text] [Related]
9. Ocular herpes simplex infection. A clinical evaluation of virus isolation and studies on iodo-deoxyuridine resistance. Nordenfelt L, Nordenfelt E. Acta Ophthalmol (Copenh); 1977 Dec 04; 55(6):919-26. PubMed ID: 202139 [Abstract] [Full Text] [Related]
10. Comparative studies on the inhibitory effects of interferon on various strains of herpes simplex viruses in vitro. Imanishi J, Matsubara M, Kishida T, Ozaki Y, Kurimura T. Biken J; 1980 Sep 04; 23(3):107-11. PubMed ID: 6161604 [Abstract] [Full Text] [Related]
11. Effect of ribavirin on Type 2 Herpesvirus hominis (HVH/2) in vitro and in vivo. Allen LB, Wolf SM, Hintz CJ, Huffman JH, Sidwell RW. Ann N Y Acad Sci; 1977 Mar 04; 284():247-53. PubMed ID: 212976 [Abstract] [Full Text] [Related]
12. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine. Yoshida T, Suzutani T, Azuma M. Tohoku J Exp Med; 1988 Nov 04; 156(3):279-90. PubMed ID: 2855280 [Abstract] [Full Text] [Related]
13. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU]. Oshima K. Nippon Ganka Gakkai Zasshi; 1967 Aug 04; 71(8):1211-6. PubMed ID: 4295686 [No Abstract] [Full Text] [Related]
14. Synergistic effect of 5'-amino-5'-deoxythymidine and 5-iodo-2'-deoxyuridine against Herpes Simplex virus infections in vitro. Fischer PH, Lee JJ, Chen MS, Lin TS, Prusoff WH. Biochem Pharmacol; 1979 Dec 01; 28(23):3483-6. PubMed ID: 231443 [No Abstract] [Full Text] [Related]
15. [Susceptibility of herpes simplex virus to IDU]. Kobayashi S, Shoji K, Asayama T. Nippon Ganka Gakkai Zasshi; 1967 Aug 01; 71(8):1201-5. PubMed ID: 4295684 [No Abstract] [Full Text] [Related]
16. [Acquired idoxuridine resistance of herpes simplex virus. Clinical data (author's transl)]. Colin J, Chastel C. Sem Hop; 1967 Aug 01; 54(33-36):1071-2. PubMed ID: 220719 [Abstract] [Full Text] [Related]
17. Physical and biological consequences of incorporation of antiviral agents into virus DNA. Prusoff WH, Mancini WR, Lin TS, Lee JJ, Siegel SA, Otto MJ. Antiviral Res; 1984 Dec 01; 4(6):303-15. PubMed ID: 6099709 [Abstract] [Full Text] [Related]
18. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro. Naito T, Shiota H, Nitta K, Mimura Y. Jpn J Ophthalmol; 1990 Dec 01; 34(1):15-21. PubMed ID: 2163462 [Abstract] [Full Text] [Related]
19. Use of the immunoperoxidase technique for estimation of susceptibility of herpes simplex virus to IDU. Sakata H, Yoshida H, Hiyama N, Kondo H, Hirakawa Y, Iwamoto T. Acta Ophthalmol (Copenh); 1983 Dec 01; 61(6):961-8. PubMed ID: 6318509 [Abstract] [Full Text] [Related]
20. [Sensitivity of herpes simplex virus to 5-iodo-2'-deoxyuridine]. Cocchi P. G Mal Infett Parassit; 1965 Dec 01; 17(12):874-6. PubMed ID: 4286637 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]